Advanced therapy medicinal products (ATMPs) are often developed under compressed timelines, with pressure to move rapidly from clinical manufacture to commercial production. Facility designs therefore need to balance immediate programme requirements with the flexibility to support future process changes, capacity increases and evolving technologies.
Wood supports cell and gene therapy projects from early planning through facility delivery, helping clients evaluate phasing strategies, manage capital investment and establish facilities that can adapt as products progress through development and commercialisation.
Designing facilities for evolving therapies
Cell and gene therapy manufacturing differs from traditional pharmaceutical production. Facilities must support complex workflows, specialised processing environments and frequently changing production requirements, often while maintaining strict quality and contamination control standards.
As therapies evolve and production volumes increase, facilities may require new equipment, revised process flows, additional utilities or expanded manufacturing areas. Designing flexibility into facilities from the outset can help reduce future disruption, avoid costly redesigns and support more efficient scale-up into GMP manufacturing.
Expertise in cell and gene therapy design
- Site master planning
- Next-generation manufacturing
- Buffer and media management
- Biocontainment
- Equipment layouts and space planning
- Constructability reviews
- CQV master planning
- Process technology assessments
- Process closure risk assessments
- Single-use system design
- Utility capacity assessments
- Manufacturing capacity and production modelling

Master planning for flexibility and growth
Many cell and gene therapy facilities begin at clinical scale before expanding to support larger commercial programmes. Early planning is therefore critical.
Our specialists optimise the movement of personnel, materials and products throughout the facility while considering future expansion, operational efficiency and compliance requirements. By incorporating approaches such as ballroom manufacturing concepts, modular layouts and single-use technologies, facilities can be configured to support future reconfiguration and growth with less disruption to ongoing operations.
Supporting next-generation manufacturing
The shift towards personalised medicines, cell therapies and gene-based treatments is driving demand for more flexible manufacturing environments. Traditional pharmaceutical facilities are not always well suited to the production models required by these therapies, creating new challenges for facility design, process integration and operational readiness.
Wood works with clients to evaluate manufacturing strategies, process technologies and facility concepts that support current production requirements while accommodating future developments. This includes assessing opportunities for process intensification, automation and digitalisation, as well as identifying ways to minimise disruption when introducing new technologies into existing operational facilities.

From facility delivery to operational readiness
Successful cell and gene therapy projects require more than facility design alone. Manufacturing readiness depends on the integration of engineering, construction, commissioning, qualification and validation activities throughout the project lifecycle.
By considering these requirements early, organisations can improve project certainty, reduce the risk of late-stage changes and support a smoother transition from construction completion to regulated manufacturing operations.
Designing for long-term performance
Cell and gene therapy manufacturing continues to evolve rapidly. Facilities commissioned today may support different therapies, technologies and production requirements in only a few years' time.
A lifecycle approach to facility design helps organisations accommodate change while protecting product quality, operational performance and regulatory compliance. By considering future adaptability alongside current requirements, facilities can continue to support growth, innovation and evolving patient needs throughout their operational life.

Our services
Delivering the best value and solutions to our clients
Beginning with the end in mind, our team of experts are here to deliver the most complex Life Science projects. From strategy and design, through construction, start-up and CQV, we apply our expertise using the latest digital tools and lean delivery concepts to bring the best value and solutions to our clients.
Providing robust, cost-effective, flexible, and compliant facilities and starting with the end goal in mind:
- Funding and permitting strategy
- Feasibility and investment case
- Site analysis and master planning
- Process definition
- Equipment selection
- Architectural modelling
- Process simulation
- Facility Digitalisation
- Test fits and building capacity assessments
- Code and life safety analysis
- Sustainability/ LEED solutions
Applying proven technology and the latest tools for seamless integrated design:
- Process architecture
- Process engineering
- Mechanical systems and clean utilities
- Instrumentation and control systems
- Electrical engineering
- Piping
- Plumbing
- Structural Engineering
- Fire protection
- 3D Modeling
- Computational flow dynamics
- Automation Engineering
- Sustainability/LEED solutions
Leveraging our global supply chain capability and strong vendor and contractor relationships:
- Procurement Strategy
- Contractor Prequalification
- Contract Negotiation and Administration
- Vendor and Contract Management
- Purchasing
- Expediting
- Material management
- Logistics
- Supplier Quality Surveillance (SQS),
- Subcontracting
Simplifying the complicated:
- World-class safety
- Program integrator
- Integrated Project Delivery
- Start-up strategy
- Pre-construction permitting
- Construction work packages (CWP)/ sequence
- Logistics plan
- Project controls
- Estimating
- Schedule & risk management
- Synchro 4D planning
- Earned value management/ change management
- Start-up & completion
- Digital delivery
Bringing a highly qualified CQV team experienced in multiple types of processes:
- Requirements definition
- Design reviews/ qualification
- Clinical quality management (CQM)/ Validation master planning (VMP)
- Risk assessments
- Program development
- Integrated scheduling
- Factory acceptance test (FAT)/Site Acceptance Test (SAT)
- CQV document development
- CQV execution
- Recertification/periodic review
- Standard operating procedures (SOP) development
- Punch list and deviation remediation and close out
- Corrective and Preventative Action (CAPA) close out
- Staff augmentation
- Current good manufacturing practices (cGMP) audits
- Training
- Decommissioning